Hadassah

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

Wednesday, Feb 7 2018

Dr. Itamar Raz

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

The Medial EarlySign's algorithm is able to identify 25 percent more patients than the current commonly used clinical tools by analyzing dozens of factors residing in Electronic Health Records, such as laboratory test results, medication, diagnostic codes, and demographics.

"The significant size and rapid growth of digital health databases now allow the application of advanced mathematical tools that can spot patterns in diverse patient populations in order to identify high-risk patients," relates Dr. Itamar Raz, Director Emeritus of the Diabetes Unit at the Hadassah Medical Organization and head of Israel’s National Diabetes Council. "Rather than relying only on small patient samples based on known risk factors,” Dr. Raz explains, “machine learning tools can reveal the slightest correlations among these parameters and discover additional risk indicators that can lead to improved prediabetic patient risk stratification (which involves classifying people into well-defined risk groups).”

By isolating less than five percent of the 400,000 diabetic patients within the company's database of 15 million patients, the algorithm was able to identify 45 percent of patients who would progress to significant kidney damage within a year. This was before they became symptomatic.

Kidney problems are one of the most common diabetes-related complications, affecting millions of people--approximately 20-40 percent of diabetics worldwide, according to Medial EarlySign. The company’s expectation is that the numbers will continue to rise as diabetes becomes more prevalent.

Learn more about the Hadassah Medical Organization.

Related Stories

alt_text

Wednesday, Dec 2 2020

Hadassah Opens Follow-Up Clinic for Recovered COVID-19 Patients

In response to the large number of COVID-19 patients suffering from lingering health issues long after they recover from the virus, Hadassah Hospital Ein Kerem has opened a multidisciplinary clinic at its Pulmonary Institute to monitor and assess their physical and psychological symptoms.

READ MORE ›
alt_text

Tuesday, Dec 1 2020

One in 200,000: Identical Triplets Born at Hadassah Hospital Mount Scopus

Last year, Tamar gave birth to a stillborn baby. When she became pregnant again, she initially didn’t rush to have an ultrasound because of the pandemic. But she wanted to make sure there was a heartbeat, and so she went to Hadassah Hospital Mount Scopus for that ultrasound. There were three heartbeats—belonging to three identical babies!

READ MORE ›
alt_text

Tuesday, Dec 1 2020

Hadassah Completes Phase I Trial With Israeli-Made COVID-19 Vaccine

Phase I of the first clinical trial with Brilife, the COVID-19 vaccine developed by the Israel Institute for Biological Research, was completed at Hadassah Hospital Ein Kerem on November 26, when the 40th participant received the final dose.

READ MORE ›
alt_text

Tuesday, Nov 24 2020

[Hadassah On Call Podcast] COVID's Long-Term Health Impact, an Insider's Perspective

It's no longer enough to find a COVID-19 cure. Each day, we're discovering long-term complications for those who have recovered from the virus.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More